We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.


Christine S. Walsh, MD

Assistant Professor, Obstetrics and Gynecology

Director, Gynecologic Oncology Fellowship Program

Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute
8700 Beverly Blvd.
North Tower, Lower Level
Los Angeles, CA 90048





Christine S. Walsh, MD

Assistant Professor, Obstetrics and Gynecology

Director, Gynecologic Oncology Fellowship Program

  • OB/GYN-Oncology

BRCA (Mutation, Positive, Carrier)

Cervical Cancers

Fallopian Tube Cancers

Gestational Trophoblast Disease

Ovarian Cancers

Pelvic Mass

Postmenopausal Bleeding

Uterine Cancers

Vaginal Cancers

Vulvar Cancers

The research of Christine S Walsh, MD, focuses on using genomic and molecular pathogenesis of ovarian cancer to identify novel biomarkers for disease prediction, prognosis, and targets for new treatment strategies. She is currently focusing her studies on genes in DNA repair pathways, cell signalling proteins and immune checkpoint inhibitors.

  • Undergraduate: Stanford University, 1994
  • Medical School: Columbia University College of Physicians and Surgeons, 1998
  • Residency: Brigham and Women's Hospital, 2002
  • Fellowship: UCLA/Cedars-Sinai, 2005
  • The American Association of Obstetricians and Gynecologists Foundation, ABOG/AAOGF Bridge Funding Award Recipient, 2014
  • APGO Faculty Teaching Award, 2011
  • Marsha Rivkin Center for Ovarian Cancer Research, Pilot Award Recipient, 2011
  • Career Development Award, Department of Defense Ovarian Cancer Research Program, 2008
  • Career Development Award, American Society of Clinical Oncology, 2008
  • UCLA Clinical and Translational Science Institute Scholars Program, 2008
  • Cedars-Sinai Medical Staff Leadership Development Program, 2008
  • Faculty Golden Apple Teaching Award, 2007
  • Career Development Award, Pacific Ovarian Cancer Research Consortium, 2007
  • Berlex Scholar Award in Basic Science Research, 2007
  • Alumni Association Award for Outstanding Service to Columbia P&S, 1998
  • Alpha Omega Alpha Medical Honor Society, 1998

Show moreShow less

  • Walsh CS. Two decades beyond BRCA1/2: homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. Gynecol Oncol. 2015;137(2):343-350.
  • Diaz ES, Walts AE, Karlan BY, Walsh CS. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival. Gynecol Oncol. 2013;131(3):541-545.
  • Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, Tran H, Miller CW, Kawamata N, Ginther C, Dering J, et al. ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol. 2008;26(18):2952-2958.
  • Walsh CS, Karlan BY. Contemporary progress in ovarian cancer screening. Curr Oncol Rep. 2007;9(6):485-493.
  • Walsh CS, Miller CW, Karlan BY, Koeffler HP. Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. Gynecol Oncol. 2006;104(3):660-664.
  • Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstetrics and Gynecology. 2005;106(4):693-699.

Show moreShow less


Make an Appointment




Available 24 Hours A Day


Send Email to Christine S. Walsh, MD